NAGL MedTech

The Medical Device Contract Manufacturing Market is expected to exceed $97B by 2026. Partnering with Contract Manufacturing partners can be challenging. Big houses, you get ignored and lost in long term contracts, smaller engineering houses lack the capability:

The NAGLREITER™ value proposition is doing more than just building great products, we aim to equally build great companies. In order to become truly great, it’s essential to have validated production capabilities that meet the commercial demands as well as the acceptable cost targets. Early commercial data and an ability to manufacture product unlocks incredible company value. For many young MedTech startups it’s equally important that this manufacturing capability is highly transferable (no strings attached) either to a Strategic acquisition or perhaps a high-volume manufacturer. At NAGLREITER™, our manufacturing activity and controlled environments are flexible enough to be conducted either in the client’s own quality system or in the NAGLREITER™ QMS.

Visit our website to learn more https://hubs.ly/H0rPS8x0.

As part of our service offerings, we have extended the usage of our telepresence Double Robotics equipment, a self-driving videoconferencing robot that allows clients to tour our facility, attend meetings, and feel more connected to the team, granting a physical presence from anywhere in the world!

NAGLREITER™ is proud to announce a Tel Aviv based partnership with Iridium Consultancy & Technologies aimed to optimally bridge Israeli medical technologies seeking a deeper presence into the US market. Click below to read the full press release!

nmddo.com

NAGLREITER™ has extensive experience in specialized coverings. Below is an example of a device that takes advantage of our electrospinning technology for an embolic agent. Contact us today to know how this specialty can aid your product development.